Shagufta Naz

Dr. Shagufta Naz

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Critical Reviews™ in Eukaryotic Gene Expression
Verified
Journal Article
Closed access
PDF file
SNShagufta Naz
Shagufta Naz
NSNida Shafique
Nida Shafique
SSSaima Sharif
Saima Sharif
FMFarkhanda Manzoor
Farkhanda Manzoor
SSSher Zaman Saifi
Sher Zaman Saifi
HKHaiba Kaul
Haiba Kaul
Interleukin-10 (IL-10) is an anti-inflammatory cytokine with lower circulating levels in type 2 diabetes mellitus (T2DM). Cytokines such as IL-10 down regulates the production of pro-inflammatory cytokines which impaired proper function of insulin. So any mutation in IL-10 gene results in increased production of pro-inflammatory cytokines, which in turn affect insulin action and cause T2DM. In the present study polymorphism (rs 1800896) in the gene (IL-10) and its association with T2DM, was determined by ARMS-PCR technique. Study subjects were divided in two groups; control and T2DM group. DNA was extracted from blood and ARMS-PCR was performed by using specific primers of promoter region. Amplified product was obtained at 258bp. In the control group heterozygous bands with both alleles (A/G) were appeared as compare to T2DM group in which AA and GG homozygosity observed. This Polymorphism (rs 1800896) in IL-10 gene is associated with T2DM. Physical measurements were also performed and difference between the groups was determined with the help of independent T-test. Significance was based on the probability level of 0.05 and highly significant based on 0.01 level of probability at 95% confidence interval

31 August 2021 in Journal of Atrial Fibrillation
Verified
Journal Article
Open access
SRSaira Rafaqat
Saira Rafaqat
SSSaima Sharif
Saima Sharif
MMMona Majeed
Mona Majeed
SNShagufta Naz
Shagufta Naz
FMFarkhanda Manzoor
Farkhanda Manzoor
SRSana Rafaqat
Sana Rafaqat
The relationship between Metabolic syndrome and Atrial Fibrillation is confirmed by many studies. The components of Metabolic syndrome cause remodeling of the atrial. Metabolic syndrome and metabolic derangements of the syndrome could be the cause of the pathogenesis of AF. This review article discusses the major biomarkers of Metabolic syndrome and their role in the pathogenesis of AF. The biomarkers are adiponectin, leptin, Leptin/ Adiponectin ratio, TNF-α, Interleukin-6, Interleukin-10, PTX3, ghrelin, uric acid, and OxLDL.The elevated plasma levels of adiponectin were linked to the presence of persistent AF. Leptin signaling contributes to angiotensin-II evoked AF and atrial fibrosis. Tumor necrosis factor-alpha involvement has been shown in the pathogenesis of chronic AF. Similarly, Valvular AF patients showed high levels of TNF-α. Increased left atrial size was associated with the interleukin-6 because it is a well-known risk factor for AF. Interleukin-10 as well as TNF-α were linked to AF recurrence after catheter ablation. PTX3 could be superior to other inflammatory markers that were reported to be elevated in AF. The serum ghrelin concentration in AF patients was reduced and significantly increased after treatment. Elevated levels of uric acid could be related to the burden of AF. Increased OxLDL was found in AF as compared to sinus rhythm control.

18 April 2016 in Iranian Journal of Science and Technology, Transactions A: Science
Verified
Journal Article
Closed access
PDF file
RARoheena Abdullah
Roheena Abdullah
NNNabiha Naeem
Nabiha Naeem
MAMahwish Aftab
Mahwish Aftab
AKAfshan Kaleem
Afshan Kaleem
MIMehwish Iqtedar
Mehwish Iqtedar
SNShagufta Naz
Shagufta Naz

13 March 2023 in Genes
Verified
Journal Article
Open access
PDF file
NINazia Ibrahim
Nazia Ibrahim
SNShagufta Naz
Shagufta Naz
FMFrancesca Mattioli
Francesca Mattioli
NGNicolas Guex
Nicolas Guex
SSSaima Sharif
Saima Sharif
ARAlexandre Reymond
Alexandre Reymond
GEMIN5 is a multifunctional RNA-binding protein required for the assembly of survival motor neurons. Several bi-allelic truncating and missense variants in this gene are reported to cause a neurodevelopmental disorder characterized by cerebellar atrophy, intellectual disability (ID), and motor dysfunction. Whole exome sequencing of a Pakistani consanguineous family with three brothers affected by ID, cerebral atrophy, mobility, and speech impairment revealed a novel homozygous 3bp-deletion NM_015465.5:c.3162_3164del that leads to the loss of NM_015465.5 (NP_056280.2):p. (Asp1054_Ala1055delinsGlu) amino acid in one of the α-helixes of the tetratricopeptide repeats of GEMIN5. In silico 3D representations of the GEMIN5 dimerization domain show that this variant likely affects the orientation of the downstream sidechains out of the helix axis, which would affect the packing with neighboring helices. The phenotype of all affected siblings overlaps well with previously reported patients, suggesting that NM_015465.5: c.3162_3164del (NP_056280.2):p. (Asp1054_Ala1055delinsGlu) is a novel GEMIN5 pathogenic variant. Overall, our data expands the molecular and clinical phenotype of the recently described neurodevelopmental disorder with cerebellar atrophy and motor dysfunction (NEDCAM) syndrome.

30 September 2010 in Gut and Liver
Verified
Journal Article
Open access
PDF file
JYJaved Yakoob
Javed Yakoob
ZAZaigham Abbas
Zaigham Abbas
SNShagufta Naz
Shagufta Naz
MIMuhammad Muinul Islam
Muhammad Muinul Islam
SAShahab Abid
Shahab Abid
WJWasim Jafri
Wasim Jafri
Yakoob J, et al. Gut Liver. 2010 Sep;4(3):345-350. http://dx.doi.org/10.5009/gnl.2010.4.3.345

29 August 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AIAfia Iqbal
Afia Iqbal
SNShagufta Naz
Shagufta Naz
HKHaiba Kaul
Haiba Kaul
SSSaima Sharif
Saima Sharif
AKAysha Khushbakht
Aysha Khushbakht
FMFarkhanda Manzoor
Farkhanda Manzoor
Aim: To identify the molecular basis of Congenital Hereditary Endothelial Dystrophy CHED caused by mutations in SLC4A11, in the consanguineous Pakistani families. Methods: A total of 7 consanguineous families affected with Congenital Hereditary Endothelial Dystrophy were diagnosed and registered with the help of ophthalmologists. Blood samples were collected from affected and unaffected members of the enrolled families. Mutational analysis was carried out by DNA sequencing using both Sanger and Whole Exome Sequencing (WES). Probands of each pedigree from the 7 families were used for WES. Results were analyzed with the help of different bioinformatics tools. Results: The sequencing results demonstrated three known homozygous mutations in gene SLC4A11 in probands of 7 families. These mutations p.Glu675Ala, p.Val824Met, and p.Arg158fs include 2 missense and 1 frameshift mutation. The mutations result in amino acids that were highly conserved in SLC4A11 across different species. The mutations were segregated with the disease phenotype in the families. Conclusion: This study reports 3 mutations in 7 families. One of the pathogenic mutations (p.R158fs) was identified for the first time in the Pakistani population. However, two mutations (p.Glu675Ala, p.Val824Met) were previously reported in two and one Pakistani family respectively. As these mutations segregate with the disease phenotype and bioinformatics tool also liable them as pathogenic, they are deemed as probable cause of underlying disease.